Biotel Inc. (BTEL) reported net income of $128,000, or $0.04 per diluted share, for the third quarter of 2009. This was down from the $328,000, or $0.11 per diluted share, reported a year earlier. Revenues in the quarter were reported at $3.2 million, up 3% from the $3.1 million reported in the third quarter of 2008.

Steve Springrose, the CEO of Biotel Inc., said, “Biotel enjoyed strong sales and earnings through the first quarter and believes its upcoming new wireless event and MCT products have favorable attributes for the arrhythmia service market.”

In April 2009, Biotel Inc. announced a merger with CardioNet, Inc. in an effort to increase its product offerings in select areas. The purchase price was $14 million or $4.82 per share.

In July 2009, CardioNet, Inc. terminated the merger agreement with Biotel, Inc., citing what it called a failure to abide by the merger agreement. Biotel, Inc. has sued CardioNet, Inc. for breach of contract.

Biotel Inc. Inc. sells medical devices, software and research services through its three operating subsidiaries – Braemar, Inc., Braemar, Inc. Distribution Center, and Agility Centralized Research Services, Inc.

Let us hear your thoughts below:

Last 5 posts by QualityStocks

• Prime Sun Power, Inc. (PSPW.OB) Up 170% After Recent QualityStocks Newsletter Coverage - February 9th, 2010
• SANUWAVE Health Inc.’s (SNWV.OB) Burn Treatment Device Receives Positive Review in Industry Publication - February 9th, 2010
• Prime Sun Power, Inc. (PSPW.OB) Pushes Photovoltaic Solar in European Market - February 9th, 2010
• WikiLoan, Inc. (WKLI.OB) Initiates Marketing Campaign - February 9th, 2010
• eDoorways Corp. (EDWY.PK) Sales Efforts Led by Retail Marketing Expert - February 9th, 2010